Literature DB >> 14748896

Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials.

N Poolsup1, C Suthisisang, S Prathanturarug, A Asawamekin, U Chanchareon.   

Abstract

OBJECTIVE: To assess the efficacy of Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection.
METHODS: Systematic review of the literature and meta-analysis of randomized controlled trials. Mean difference in the reduction in symptom severity scores between treatment and control groups was calculated to obtain an overall estimate of effect.
RESULTS: Four studies met our inclusion criteria and were reviewed. A total of 433 patients reported in three trials were included in the statistical analysis. Andrographis paniculata fixed combination with Acanthopanax senticosus was more effective than placebo. The mean difference was 2.13 points (95% CI 1.00-3.26 points, P=0.0002) on the symptom severity score. The difference in effects between A. paniculata and placebo was 10.85 points (95% CI 10.36-11.34 points, P<0.0001) in favour of A. paniculata.
CONCLUSION: Current evidence suggests that A. paniculata extract alone or in combination with A. senticosus extract may be more effective than placebo and may be an appropriate alternative treatment of uncomplicated acute upper respiratory tract infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748896     DOI: 10.1046/j.1365-2710.2003.00534.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  24 in total

1.  Inhibitory effects of andrographolide on activated macrophages and adjuvant-induced arthritis.

Authors:  Swati Gupta; Kamla Prasad Mishra; Shashi Bala Singh; Lilly Ganju
Journal:  Inflammopharmacology       Date:  2017-07-22       Impact factor: 4.473

2.  A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP.

Authors:  Wan-Jung Lu; Jie-Jen Lee; Duen-Suey Chou; Thanasekaran Jayakumar; Tsorng-Han Fong; George Hsiao; Joen-Rong Sheu
Journal:  J Mol Med (Berl)       Date:  2011-08-06       Impact factor: 4.599

3.  Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer.

Authors:  Chengfei Liu; Nagalakshmi Nadiminty; Ramakumar Tummala; Jae Yeon Chun; Wei Lou; Yezi Zhu; Meng Sun; Christopher P Evans; Qinghua Zhou; Allen C Gao
Journal:  Genes Cancer       Date:  2011-02

4.  Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata.

Authors:  Shuo Yang; Andrew M Evens; Sheila Prachand; Amareshwar T K Singh; Savita Bhalla; Kevin David; Leo I Gordon
Journal:  Clin Cancer Res       Date:  2010-08-26       Impact factor: 12.531

5.  Andrographolide radiosensitizes human ovarian cancer SKOV3 xenografts due to an enhanced apoptosis and autophagy.

Authors:  Chao Zhang; Xingsheng Qiu
Journal:  Tumour Biol       Date:  2015-05-28

Review 6.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.

Authors:  R A Burgos; J L Hancke; J C Bertoglio; V Aguirre; S Arriagada; M Calvo; D D Cáceres
Journal:  Clin Rheumatol       Date:  2009-04-29       Impact factor: 2.980

8.  In situ imaging and proteome profiling indicate andrographolide is a highly promiscuous compound.

Authors:  Lin Li; Hadhi Wijaya; Sanjay Samanta; Yulin Lam; Shao Q Yao
Journal:  Sci Rep       Date:  2015-06-24       Impact factor: 4.379

9.  Andrographis paniculata extract (HMPL-004) for active ulcerative colitis.

Authors:  William J Sandborn; Stephan R Targan; Vera S Byers; Dean A Rutty; Hua Mu; Xun Zhang; Tom Tang
Journal:  Am J Gastroenterol       Date:  2012-10-09       Impact factor: 10.864

10.  Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide.

Authors:  Thanasekaran Jayakumar; Cheng-Ying Hsieh; Jie-Jen Lee; Joen-Rong Sheu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.